HRT Financial
SBFM icon

HRT Financial’s Sunshine Biopharma SBFM Stock Holding History

HRT Financial’s Portfolio SBFM Stock Details SBFM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-11
Closed -$18K – 3041
2024
Q2 		$18K Buy
+11
New +$105K ﹤0.01% 1943
2024
Q1 		– Hold
0
– – – 2176
2023
Q4 		– Hold
0
– -$5K – 2981
2023
Q3 		– Hold
0
– – – 2185

Other funds holding SBFM

Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Nordwand Advisors
Nordwand Advisors Radnor, Pennsylvania $630M AUM 27.11% 1-Year Est. Return
National Bank of Canada
National Bank of Canada Montreal, Quebec, Canada $140B AUM 46.34% 1-Year Est. Return
Farther Finance Advisors
Farther Finance Advisors San Francisco, California $14.2B AUM 18.33% 1-Year Est. Return
Federation des caisses Desjardins du Quebec
Federation des caisses Desjardins du Quebec Levis, Quebec, Canada $32.7B AUM 35.71% 1-Year Est. Return
Jaffetilchin Investment Partners
Jaffetilchin Investment Partners Tampa, Florida $1.89B AUM 26.73% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $83.6B AUM 19.78% 1-Year Est. Return
Rise Advisors
Rise Advisors Rochester, New York $355M AUM 12.65% 1-Year Est. Return
TD Waterhouse Canada
TD Waterhouse Canada Toronto, Ontario, Canada $38.4B AUM 30.28% 1-Year Est. Return

HRT Financial's SBFM Position: Q3 2024 in Review

HRT Financial sold out of Sunshine Biopharma (SBFM) in Q3 2024, closing a stake of 11 shares — an estimated $18K sold.

HRT Financial first reported a position in SBFM in Q2 2024 and held it in 1 quarter. The position peaked at $18K in Q2 2024. 2 funds tracked by Wall St. Rank hold SBFM as of Q3 2024.

  • HRT Financial reported no remaining Sunshine Biopharma position as of Q3 2024 after selling out during the quarter.
  • HRT Financial sold 11 Sunshine Biopharma shares in Q3 2024, an estimated $18K.
  • HRT Financial first reported a position in Sunshine Biopharma in Q2 2024 and held it in 1 quarter.
  • HRT Financial's Sunshine Biopharma position peaked at $18K in Q2 2024.
  • 2 funds tracked by Wall St. Rank held Sunshine Biopharma as of Q3 2024.

Based on HRT Financial's 13F filing for Q3 2024, filed 12 Nov 2024.